Related Experiment Video

Updated: Jul 7, 2026

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

[Transmyocardial laser revascularization]

Muzaffer Bahçivan1, Hasan Tahsin Keçeligil, Ferşat Kolbakir

  • 1Ondokuz Mayis Universitesi, Tip Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dali, Samsun, Türkiye. mbahcivan@omu.edu.tr

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|February 9, 2008
PubMed

Insights

Transmyocardial laser revascularization (TMR) improves angina and quality of life for patients unsuitable for conventional treatments. However, TMR does not impact survival or cardiac events, with further research pending.

Area of Science:

  • Cardiology
  • Minimally Invasive Surgery

Context:

  • Conventional revascularization methods are unsuitable for a growing number of patients with refractory angina pectoris.
  • Transmyocardial laser revascularization (TMR) offers an alternative when bypass surgery or angioplasty is not indicated.

Purpose:

  • To evaluate the effectiveness of Transmyocardial laser revascularization (TMR) in patients with refractory angina pectoris.
  • To assess the impact of TMR on angina symptoms, quality of life, and clinical outcomes.

Summary:

  • Transmyocardial laser revascularization (TMR) significantly alleviates angina symptoms and enhances the quality of life for eligible patients.
  • The procedure also leads to reduced hospital readmissions and potential improvements in exercise tolerance.
  • Importantly, TMR has not demonstrated an effect on survival rates, ejection fraction, cardiac events, or myocardial perfusion.

Impact:

  • TMR provides a viable treatment option for select patients with refractory angina, improving symptomatic relief and daily living.
  • While not affecting long-term survival or major cardiac events, TMR offers significant palliative benefits.
  • Ongoing clinical trials are expected to provide further insights into the long-term efficacy and role of TMR in cardiovascular care.

More Related Videos

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice08:28

Induction of Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury in Mice

Published on: January 19, 2022

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...